Showing results (141-150 of 391) with videos related to

Sort By:
Pageof 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapseFrancois-Clément Bidard, Anne Vincent-Salomon, Stéphanie Gomme, et al.
BMC Cancer|April 25, 2019
HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reportsAlexandra Arfi, Delphine Hequet, Guillaume Bataillon, et al.
Breast Cancer Research : BCR|July 16, 2020
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancerClaire Bonneau, Antoine Eliès, Yann Kieffer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2020
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinomaJean-Christophe Tille, André F Vieira, Caroline Saint-Martin, et al.
Frontiers in Cardiovascular Medicine|October 7, 2021
PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion InjuryNitirut Nernpermpisooth, Charlotte Sarre, Christian Barrere, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 9, 2007
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstMarc A Bollet, Brigitte Sigal-Zafrani, Valérie Mazeau, et al.
Physiological Reports|January 21, 2015
Low glucose microenvironment of normal kidney cells stabilizes a subset of messengers involved in angiogenesisElodie de Laplanche, Asma Boudria, Estelle Dacheux, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapyAnne Vincent-Salomon, Alexandra Rousseau, Michel Jouve, et al.
Pageof 40